Hiroshige Kojima
- Epidemiology top 10%
- Hepatology top 5%
- Molecular Biology
- Physiology
- Infectious Diseases
- Co-authors
- Osamu YokosukaFumio ImazekiHiromitsu SaishoMasao OmataKenichi FukaiTatsuo KandaTetsuhiro ChibaManna Zhang
- Topics
- Hepatitis B Virus Studies (9 papers)Liver Disease Diagnosis and Treatment (8 papers)Hepatitis C virus research (8 papers)
- Partner nations
- JapanCanadaUnited States
In The Last Decade
Hiroshige Kojima
22 papers receiving 529 citations
Peers
Comparison fields: 5 of 69
- Epidemiology 275
- Hepatology 257
- Molecular Biology 158
- Physiology 104
- Infectious Diseases 58
Countries citing papers authored by Hiroshige Kojima
This map shows the geographic impact of Hiroshige Kojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Kojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Kojima more than expected).
Fields of papers citing papers by Hiroshige Kojima
This network shows the impact of papers produced by Hiroshige Kojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Kojima. The network helps show where Hiroshige Kojima may publish in the future.
Co-authorship network of co-authors of Hiroshige Kojima
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Kojima. A scholar is included among the top collaborators of Hiroshige Kojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Kojima. Hiroshige Kojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab]. | 1 |
| 3 | 14 | |
| 4 | [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. | 2 |
| 5 | 88 | |
| 6 | 9 | |
| 7 | 52 | |
| 8 | 15 | |
| 9 | 84 | |
| 10 | 1 | |
| 11 | 17 | |
| 12 | 28 | |
| 13 | 21 | |
| 14 | 10 | |
| 15 | [A case of steatohepatitis associated with tamoxifen]. | 1 |
| 16 | 8 | |
| 17 | 41 | |
| 18 | 2 | |
| 19 | [Diagnosis and treatment of pulmonary tuberculosis complicated with chronic liver disease]. | 3 |
| 20 | 130 |
About Hiroshige Kojima
Hiroshige Kojima is a scholar working on Hepatology, Aging and Epidemiology, having authored 22 papers that have together received 552 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Hepatology (257 citations), Epidemiology (275 citations) and Animal Science and Zoology (47 citations). Hiroshige Kojima has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Osamu Yokosuka, Fumio Imazeki, Hiromitsu Saisho, Masao Omata, Kenichi Fukai, Tatsuo Kanda, Tetsuhiro Chiba, Manna Zhang, Gerald Y. Minuk and Motohisa Tada. Their work appears in journals such as Gastroenterology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.